PANOVA-3: A phase III study of TTFields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC)

被引：0

作者：

Weinberg, Uri ^{[1
]}

Farber, Ori ^{[2
]}

Giladi, Moshe ^{[2
]}

Bomzon, Zeev ^{[2
]}

Lavy-Shahaf, Gitit ^{[2
]}

Kirson, Eilon D. ^{[2
]}

机构：

[1] Novocure GmbH, Root, Switzerland

[2] Novocure, Haifa, Israel

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-CT157

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT157

引用

页数：2

共 50 条

[1] PANOVA-3: A phase III trial of TTFields with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
Weinberg, U.
Farber, O.
Kinzel, A.
Giladi, M.
Bomzon, Z.
Kirson, E.
STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S164 - S164
[2] PANOVA-3: A phase 3 study of TTFields with gemcitabine and nab-paclitaxel for front-line treatment of locally- advanced pancreatic adenocarcinoma (LAPC)
Farber, O.
Weinberg, U.
Bomzon, Z.
Giladi, M.
Kirson, E. D.
ANNALS OF ONCOLOGY, 2017, 28
[3] A phase III trial of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC): PANOVA-3
Picozzi, V. J.
Macarulla Mercade, T.
Philip, P. A.
Becerra, C. R.
Dragovich, T.
ANNALS OF ONCOLOGY, 2020, 31 : S955 - S955
[4] PANOVA-3: A phase 3 study of TTFields with gemcitabine and nabpaclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC)
Uri, Weinberg
Ori, Faber
Moshe, Giladi
Ze'ev, Bomzon
Eilon, Kirson
ANNALS OF ONCOLOGY, 2017, 28
[5] A phase III trial of tumor-treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC): PANOVA-3
Picozzi, Vincent J.
Macarulla, Teresa
Philip, Philip Agop
Becerra, Carlos Roberto
Dragovich, Tomislav
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[6] PANOVA-3: A phase III study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC).
Picozzi, Vincent J.
Macarulla, Teresa
Philip, Agop Philip
Becerra, Carlos Roberto
Dragovich, Tomislav
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[7] PANOVA-3: A phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic adenocarcinoma
Picozzi, Vincent J.
Macarulla, Teresa
Philip, Philip A.
Becerra, Carlos Roberto
Dragovich, Tomislav
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[8] PANOVA-3: A phase III study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma.
Picozzi, Vincent J.
Macarulla, Teresa
Philip, A. Philip
Becerra, Carlos R.
Dragovich, Tomislav
CANCER RESEARCH, 2021, 81 (22) : 35 - 36
[9] Phase III PANOVA study of tumor treating fields (150 kHz) in combination with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC)
Weinberg, Uri
Farber, Ori
Giladi, Moshe
Bomzon, Zeev
Kirson, Eilon
CANCER RESEARCH, 2019, 79 (13)
[10] Front-line treatment of locally advanced pancreatic adenocarcinoma with tumour treating fields concomitant with gemcitabine and nab-paclitaxel: The phase 3 PANOVA-3 study
Picozzi, V.
Macarulla, T.
Philip, P.
Becerra, C.
Dragovich, T.
ANNALS OF ONCOLOGY, 2022, 33 : S292 - S292

← 1 2 3 4 5 →